Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 282

1.

Clinical toxicology of newer recreational drugs.

Hill SL, Thomas SH.

Clin Toxicol (Phila). 2011 Oct;49(8):705-19. doi: 10.3109/15563650.2011.615318. Review. Erratum in: Clin Toxicol (Phila). 2011 Nov;49(9):880.

PMID:
21970769
[PubMed - indexed for MEDLINE]
2.

The clinical toxicology of the designer "party pills" benzylpiperazine and trifluoromethylphenylpiperazine.

Schep LJ, Slaughter RJ, Vale JA, Beasley DM, Gee P.

Clin Toxicol (Phila). 2011 Mar;49(3):131-41. doi: 10.3109/15563650.2011.572076. Review.

PMID:
21495881
[PubMed - indexed for MEDLINE]
3.

2C or not 2C: phenethylamine designer drug review.

Dean BV, Stellpflug SJ, Burnett AM, Engebretsen KM.

J Med Toxicol. 2013 Jun;9(2):172-8. doi: 10.1007/s13181-013-0295-x. Review.

PMID:
23494844
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

GHB and synthetic cathinones: clinical effects and potential consequences.

Karila L, Reynaud M.

Drug Test Anal. 2011 Sep;3(9):552-9. doi: 10.1002/dta.210. Epub 2010 Dec 2. Review.

PMID:
21960540
[PubMed - indexed for MEDLINE]
5.

3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans.

Steele TD, McCann UD, Ricaurte GA.

Addiction. 1994 May;89(5):539-51. Review.

PMID:
7913850
[PubMed - indexed for MEDLINE]
6.

Abuse liability profile of three substituted tryptamines.

Gatch MB, Forster MJ, Janowsky A, Eshleman AJ.

J Pharmacol Exp Ther. 2011 Jul;338(1):280-9. doi: 10.1124/jpet.111.179705. Epub 2011 Apr 7.

PMID:
21474568
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

German CL, Fleckenstein AE, Hanson GR.

Life Sci. 2014 Feb 27;97(1):2-8. doi: 10.1016/j.lfs.2013.07.023. Epub 2013 Aug 2. Review.

PMID:
23911668
[PubMed - indexed for MEDLINE]
8.

The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain.

Nagai F, Nonaka R, Satoh Hisashi Kamimura K.

Eur J Pharmacol. 2007 Mar 22;559(2-3):132-7. Epub 2006 Dec 12.

PMID:
17223101
[PubMed - indexed for MEDLINE]
9.

Use and acute toxicity associated with the novel psychoactive substances diphenylprolinol (D2PM) and desoxypipradrol (2-DPMP).

Wood DM, Dargan PI.

Clin Toxicol (Phila). 2012 Sep;50(8):727-32. doi: 10.3109/15563650.2012.716158. Epub 2012 Aug 10. Review.

PMID:
22882169
[PubMed - indexed for MEDLINE]
10.

Ecstasy (3,4-methylenedioxymethamphetamine): history, neurochemistry, and toxicology.

Rochester JA, Kirchner JT.

J Am Board Fam Pract. 1999 Mar-Apr;12(2):137-42. Review.

PMID:
10220237
[PubMed - indexed for MEDLINE]
11.

[Entactogenic drugs "ecstasy" (MDMA), "eve" (MDE) and other ring-substituted methamphetamine derivatives. A new class of substances among illegal designer drugs?].

Gouzoulis-Mayfrank E, Hermle L, Kovar KA, Sass H.

Nervenarzt. 1996 May;67(5):369-80. Review. German.

PMID:
9005345
[PubMed - indexed for MEDLINE]
12.

Metabolism of designer drugs of abuse: an updated review.

Meyer MR, Maurer HH.

Curr Drug Metab. 2010 Jun 1;11(5):468-82. Review.

PMID:
20540700
[PubMed - indexed for MEDLINE]
13.

In vitro screening of psychoactive drugs by [(35)S]GTPgammaS binding in rat brain membranes.

Nonaka R, Nagai F, Ogata A, Satoh K.

Biol Pharm Bull. 2007 Dec;30(12):2328-33.

PMID:
18057721
[PubMed - indexed for MEDLINE]
Free Article
14.

The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone).

Dargan PI, Sedefov R, Gallegos A, Wood DM.

Drug Test Anal. 2011 Jul-Aug;3(7-8):454-63. doi: 10.1002/dta.312. Epub 2011 Jul 13. Review.

PMID:
21755604
[PubMed - indexed for MEDLINE]
15.

Synthetic cathinones: chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as "bath salts" or "plant food".

Coppola M, Mondola R.

Toxicol Lett. 2012 Jun 1;211(2):144-9. doi: 10.1016/j.toxlet.2012.03.009. Epub 2012 Mar 21. Review.

PMID:
22459606
[PubMed - indexed for MEDLINE]
16.

Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines.

Winter JC.

Psychopharmacology (Berl). 2009 Apr;203(2):251-63. doi: 10.1007/s00213-008-1356-8. Epub 2008 Nov 1.

PMID:
18979087
[PubMed - indexed for MEDLINE]
17.

3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online.

Coppola M, Mondola R.

Toxicol Lett. 2012 Jan 5;208(1):12-5. doi: 10.1016/j.toxlet.2011.10.002. Epub 2011 Oct 8. Review.

PMID:
22008731
[PubMed - indexed for MEDLINE]
18.

[Mephedrone: a designer drug of recent use in France].

Debruyne D, Courné MA, Le Boisselier R, Djezzar S, Gérardin M, Boucher A, Karila L, Coquerel A, Mallaret M.

Therapie. 2010 Nov-Dec;65(6):519-24. Epub 2010 Dec 23. Review. French.

PMID:
21176758
[PubMed - indexed for MEDLINE]
19.

Measurement of 3,4-MDMA and related amines in diagnostic and forensic laboratories.

Skrinska VA, Gock SB.

Clin Lab Sci. 2005 Spring;18(2):119-23. Review.

PMID:
15916245
[PubMed - indexed for MEDLINE]
20.

Toxicity of amphetamines: an update.

Carvalho M, Carmo H, Costa VM, Capela JP, Pontes H, Remião F, Carvalho F, Bastos Mde L.

Arch Toxicol. 2012 Aug;86(8):1167-231. doi: 10.1007/s00204-012-0815-5. Epub 2012 Mar 6. Review.

PMID:
22392347
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk